SES AUA 2025 high-risk biochemically recurrent prostate cancer, enzalutamide monotherapy treatment, phase 3 EMBARK study, EMBARK (NCT02319837).
Peyronie’s Disease, Molecular Hallmarks of Peyronie’s Disease, tyrosine kinase inhibitor, transforming growth factor-beta (TGF-β), Matrix metalloproteinases (MMP) enzymes, Tissue inhibitors of metalloproteinases proteins (TIMP), pirfenidone,…
Testicular cancer, Testicular germ cell tumor (TGCT), Retroperitoneal Lymph Node Dissection (RPLND), pathological lymph node staging, clinical stage (CS) II seminomatous TGCT.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with
HHS Secretary Robert F. Kennedy Jr. declared that the new administration will identify an environmental toxin causing autism in a matter of months, but experts…
Jeff wrote this article for Hospitals & Health Networks in the July 5, 1998 edition. He republished it this week on his substack calling it…
The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers
Even before tariffs hit on the pharma industry, drugmakers are considering ways to try to soften their blow.
Benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), Holmium Laser Enucleation of the prostate cancer (HoLEP), Advancing Holmium Laser Enucleation, American Urological Association Symptom…
Home health companies said the prospect of higher medical supply costs from tariffs and high labor costs are forcing them to play hardball with insurers…
